Concepedia

Douglas S. Campbell

DS

25

Publications

4.7K

Citations

18

H-Index

1984

Active since

Affiliations

University of Cambridge(Current)

University of Utah

AstraZeneca (United Kingdom)

Erasmus MC

German Center for Neurodegenerative Diseases

Douglas S. Campbell is an author at University of Cambridge specializing in medicine, cell biology, and cell signaling.

ORCID

Top concepts

Publications per year

1984–2023

25

Publications

25

The Tol2kit: A multisite gateway‐based construction kit for <i>Tol2</i> transposon transgenesis constructs

Kristen M. Kwan, E. Fujimoto, Clemens Grabher et al. · Developmental Dynamics · 2007 · 1.9K citations

Chemotropic Responses of Retinal Growth Cones Mediated by Rapid Local Protein Synthesis and Degradation

Douglas S. Campbell, Christine E. Holt · Neuron · 2001 · 773 citations · Full text

, , +7

Axonal Protein Synthesis and Degradation Are Necessary for Efficient Growth Cone Regeneration

Poonam Verma, Sabrina Chierzi, A. Mortime Codd et al. · Journal of Neuroscience · 2005 · 406 citations · Full text

Apoptotic Pathway and MAPKs Differentially Regulate Chemotropic Responses of Retinal Growth Cones

Douglas S. Campbell, Christine E. Holt · Neuron · 2003 · 289 citations · Full text

, , +8

E3 Ligase Nedd4 Promotes Axon Branching by Downregulating PTEN

Jována Drinjákovic, Hosung Jung, Douglas S. Campbell et al. · Neuron · 2010 · 200 citations · Full text

Rows per page

1–5 of 25